ypradat @ypradat

Postdoctoral researcher. Translational Research, Applied Mathematics, Computational Biology, Oncology. @GustaveRoussy @PrismCenter @FondationARC Paris Joined November 2019

Tweets

29
Followers

50
Following

50
Likes

129

ypradat @ypradat

12 months ago

Just left #MAP2024 with inspiring talks x current hot topics in oncology! I was very pleased to cross path again with @PapaemmanuilLab and to attend with colleagues S. Dogan, @FAndreMD, @Elsa2Bernard from @GustaveRoussy. Many thanks to @FondationARC for the travel grant.

0 0 4 82 0

ypradat @ypradat

2 years ago

I am thrilled to announce that I will be supported by a postdoctoral fellowship from @FondationARC for the next 3y to investigate the molecular features of treatment-related myeloid leukemias. Work under the supervision of @Elsa2Bernard at @GustaveRoussy and part of @PrismCenter.

3 1 22 6K 0

FabriceAndre @FAndreMD

2 years ago

1st award @myESMO : I Ray-Coquard on rare gyne cancers. How to improve outcome: precise dg (referral), quality of network (infrastructure & scient collab), guidelines adh, inclusion of all stakeholders, database, biomarker driven approvals. @PrismCenter cited ! #ESMO2023

1 7 41 4K 0

Download Image

Paolo Tarantino @PTarantinoMD

2 years ago

The DAISY trial of T-DXd in MBC with variable HER2 expression is out on @NatureMedicine. Many important findings, including a similar ORR with T-DXd in HER2-low (37.5%) & HER2-0 (29.7%) MBC. Congrats to @FerMosele @FAndreMD et al for this impressive work! nature.com/articles/s4159…

8 83 255 54K 33

Download Image

Edwin Cuppen @ecuppen

2 years ago

Very proud to see our work on the pan-cancer comparison of the genomic landscapes of primary and metastatic tumor published in this weeks issue of Nature: nature.com/articles/s4158…. @fran_mj88 @arne_van_hoeck @HartwigMedical @UMCU_CMM @oncodeinstitute @VHIO

1 50 147 19K 38

FabriceAndre @FAndreMD

2 years ago

.@PrismCenter selected to receive 30-40 M euros to build a Precision Oncology Center. Vision: to classify pts based on biology. Scientific strategy: bottom-up approach to model cancer biology in each pt (fig 2) for early cancer or relapse detection, & tt optimisation (fig 3).

12 37 146 20K 15

Download Image

ISB-CGC @isb_cgc

2 years ago

We financially and technically supported a pan-TCGA WES analysis in the @CD_AACR paper "Integrative #Pancancer Genomic and Transcriptomic Analyses of Refractory #Metastatic Cancer" by @ypradat, @DGautheret, @snikolae et al. aacrjournals.org/cancerdiscover… @PrismCenter @GustaveRoussy

2 2 4 1K 0

Daniel Gautheret @DGautheret

2 years ago

Now presenting metaPRISM. Come and visit us @AACR poster section 31. @GustaveRoussy @UnivParisSaclay

2 5 24 2K 2

Download Image

Frank Harrell @f2harrell

3 years ago

#Statistics thought of the day: futility of much high-dimensional omics research (false discovery rates be damned): when N<p there is often no correlation between estimated and actual effects hbiostat.org/bbr/hdata.html…

5 26 126 32K 52

Download Image

Cancer Discovery @CD_AACR

3 years ago

Integrative #Pancancer Genomic and Transcriptomic Analyses of Refractory #Metastatic Cancer, by @ypradat, @DGautheret, @snikolae et al. bit.ly/3Yq5XaL @PrismCenter @GustaveRoussy @centralesupelec @ParisSaclay @Inserm

0 12 22 4K 2

Download Image

Elizabeth McKenna @ElizSMcKenna

3 years ago

Now online in @CD_AACR: Integrative Pan-cancer Genomic and Transcriptomic Analyses of Refractory #Metastatic Cancer - by @ypradat @DGautheret Sergey Nikolaev and colleagues @PrismCenter @GustaveRoussy @centralesupelec @ParisSaclay @Inserm aacrjournals.org/cancerdiscover…

1 7 41 7K 3

Download Image

Hematopoiesis News @Hema_News

3 years ago

📯 Hear ye! Hear ye! The #TopTweet is presented to thee! 🥂 Congratulations to the team with Drs. Yanis Tazi (@TaziYanis) and Ellie Papaemmanuil (@PapaemmanuilLab) from @MSKCancerCenter on the development of an open-access clinical decision support tool!

Hematopoiesis News @Hema_News

3 years ago

0 7 35 0 4

Download Image

0 2 5 2K 0

Eytan Ruppin, MD, PhD @EytanRuppin

3 years ago

👉META-PRISM: 1,031 pan-cancer refractory metastatic tumors profiled via whole-exome and transcriptome sequencing. medrxiv.org/content/10.110…

0 42 127 0 28

Download Image

FabriceAndre @FAndreMD

3 years ago

Tks anirban ! RNA seq and whole exome in 1000 and 500 pretreated metastatic cancers. Interesting to see the impact of prior therapies, especially platinum, on DNA + discovery of new alterations involved in resistance (PTEN transloc). A huge work from PRISM (maybe futur center🤞)

Anirban Maitra @Aiims1742

3 years ago

0 23 60 0 8

Download Image

0 14 37 0 5

ypradat @ypradat

3 years ago

WES & RNAseq landscape of > 1,000 multi-resistant tumors treated @GustaveRoussy highlights the current gap in understanding treatment resistances. Preprint medrxiv.org/cgi/content/sh…. Data will be made available upon release in peer-reviewed journal. @centralesupelec @PrismCenter.

0 6 19 0 1

Download Image

FabriceAndre @FAndreMD

3 years ago

4 yrs ago, we discussed with Mathematicians ⁦@centralesupelec⁩ about integrating Maths in Cancer Research projects⁩. It’s nice to see papers coming on Mathematical models of cancer from our teams. Here a modeling of myeloproliferative disorders 👇 pnas.org/doi/10.1073/pn…

0 8 52 0 3

ypradat @ypradat

3 years ago

Proud to have been part of this fantastic study and of Papaemmanuil's team! This work contributes to improving our understanding of highly-aggressive AML tumors and hopefully will help medical doctors better assess the risk profile of each patient.

Elli Papaemmanuil, PhD @PapaemmanuilLab

3 years ago

11 43 128 0 20

0 0 3 0 0

ypradat @ypradat

3 years ago

Very pleased and honored to have had the opportunity to present the first results of our study on META-PRISM, a cohort of > 1,000 very aggressive metastatic tumors. Thanks to @GustaveRoussy, @PrismCenter & @centralesupelec for making this possible. #ESHG2022